Company intelligence / Profile preview

Aevice Health

Ownership: Private
Development stage: Commercial

Overview

Aevice Health’s flagship product, the AeviceMD wearable stethoscope, has received regulatory approval in Singapore and the United States. It enables continuous home monitoring of lung sounds, heart rate, respiratory rate, and wheezing to detect early signs of deterioration in asthma or COPD patients. The device provides actionable insights to clinicians for timely intervention. Clinical validation has led to regulatory clearances including US FDA clearance for pediatric use.

Therapeutic areas: Pulmonology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Denka Co., Ltd. (strategic investment & joint R&D in AI-powered electronic stethoscopes/respiratory health with Denka’s expertise in infectious diseases/immunology)Elev8 Venture Partners/Elev8.vc

Beyond the preview

Go deeper on Aevice Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aevice Health.

Explore the full profile